The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGulf Marine Services Regulatory News (GMS)

Share Price Information for Gulf Marine Services (GMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.40
Bid: 22.30
Ask: 22.70
Change: -0.60 (-2.61%)
Spread: 0.40 (1.794%)
Open: 22.60
High: 22.70
Low: 22.30
Prev. Close: 23.00
GMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Gulf Marine Services plc

1 May 2020 14:17

Aberforth Partners LLP - Form 8.3 - Gulf Marine Services plc

Aberforth Partners LLP - Form 8.3 - Gulf Marine Services plc

PR Newswire

London, May 1

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Aberforth Partners LLP, on behalf of discretionary clients.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Gulf Marine Services plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 30/04/2020
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/A NO If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled: 69,831,569 19.92% 0 0.0
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 69,831,569 19.92% 0 0.0

Aberforth Partners LLP does not have discretion regarding voting decisions in respect of 23,449,440 shares included in the total disclosed above. This total includes 23,449,440 shares held by The Wellcome Trust, who retain voting control over their shareholding. No other client, who falls into this category, holds more than 1% of the relevant security.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:N/A
Details, including nature of the rights concerned and relevant percentages:N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
N/A- Opening Disclosure

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure: 01 May 2020
Contact name:Michael Campbell, for Aberforth Partners LLP
Telephone number:0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
18th Apr 20245:55 pmRNSAnnual Report & Notice of AGM
4th Apr 20247:00 amRNSFinal Results
11th Mar 20247:00 amRNSNew Contract Announcement and Letter of Award
28th Feb 20248:14 amRNSContract
17th Jan 20247:00 amRNSRevised Guidance
8th Jan 20247:00 amRNSContracts
6th Nov 20237:00 amRNSTrading Update
1st Nov 20237:00 amRNSContract
11th Oct 20237:00 amRNSBoard Appointment
31st Aug 20237:00 amRNSInterim results
4th Aug 20237:00 amRNSDirectorate Change
18th Jul 20237:00 amRNSDecrease in Financing Charges
12th Jun 20237:00 amRNSContract
7th Jun 20231:15 pmRNSResult of AGM
10th May 20234:46 pmRNSDirector / PDMR Shareholdings
4th May 20237:00 amRNSHealth & Safety Milestone
28th Apr 20235:02 pmRNSAnnual Report and Notice of AGM
24th Apr 20237:00 amRNSFinal Results
29th Mar 20237:00 amRNSContract
10th Feb 20237:30 amRNSDirector/PDMR Shareholding
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSContract
13th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSTrading Statement
3rd Jan 20237:00 amRNSIssue of Warrants
14th Dec 20227:00 amRNSWarrant Calculations
9th Dec 20227:00 amRNSTrading Update
25th Nov 202211:37 amRNSHolding(s) in Company
15th Nov 20227:00 amRNSContract
3rd Nov 20227:00 amRNSTwo New Contract Awards and A Contract Extension
19th Oct 20223:10 pmRNSResults of General Meeting
29th Sep 20227:00 amRNSContract
28th Sep 20225:04 pmRNSPublication of Shareholder Circular & Notice of GM
27th Sep 20227:00 amRNSContract
26th Sep 20227:00 amRNSInterim results for the six months ended 30/06/22
1st Sep 20224:40 pmRNSSecond Price Monitoring Extn
1st Sep 20224:35 pmRNSPrice Monitoring Extension
30th Jun 20221:10 pmRNSResult of AGM
15th Jun 20227:30 amRNSGrant of Director Share Awards
7th Jun 20225:30 pmRNS2021 Annual Report and Notice of 2022 AGM
13th May 20227:10 amRNSAnnual Financial Report
29th Apr 20227:00 amRNSContract
17th Feb 20227:00 amRNSContract
7th Feb 20227:00 amRNSAppointment of Chief Financial Officer
1st Feb 20228:09 amRNSDirector/PDMR Shareholding
25th Jan 20227:00 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSTrading Update
21st Dec 20217:00 amRNSContract
20th Dec 20214:41 pmRNSSecond Price Monitoring Extn
20th Dec 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.